SCHEMBL5146089

SCHEMBL5146089

COc1ccc(-c2ccsc2CC=O)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 3/20 0.47
MAPT P10636 2/20 0.40
KDM4E B2RXH2 1/20 0.39
CYP1A2 P05177 1/20 0.39
CYP2D6 P10635 1/20 0.39
CYP2C9 P11712 1/20 0.39
CYP2C19 P33261 1/20 0.39
ALDH1A1 P00352 2/20 0.38
CYP2A6 P11509 1/20 0.38
PTGS1 P23219 1/20 0.38
APP P05067 1/20 0.37
GABRA1 P14867 1/20 0.37
GABRG2 P18507 1/20 0.37
GABRB3 P28472 1/20 0.37
GABRA3 P34903 1/20 0.37
GABRA2 P47869 1/20 0.37
ABL1 P00519 1/20 0.37
ABCB1 P08183 1/20 0.37
BCR P11274 1/20 0.37
BACE1 P56817 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5147356 0.78 BCAT2 (0.43) PTGS2ALDH1A1PTGS1PTPN1
SCHEMBL15009038 0.74 KEAP1 (0.60) KDM4ECYP1A2CYP2D6CYP2C19ALDH1A1
SCHEMBL7502836 0.74 PTGS2 (0.49) PTGS2MAPTALDH1A1CYP2A6PTGS1
SCHEMBL7797358 0.73 PTPN1 (0.60) PTGS2KDM4EALDH1A1ABL1ABCB1
SCHEMBL19287149 0.72 ALDH1A1 (0.59) MAPTALDH1A1CYP2A6SMN1; SMN2
SCHEMBL1515689 0.71 ABL1 (0.50) MAPTKDM4ECYP1A2CYP2D6CYP2C9
SCHEMBL27538658 0.71 MAPT (0.44) PTGS2MAPTKDM4ECYP1A2CYP2C9
SCHEMBL8038496 0.71 PTGS2 (0.51) PTGS2MAPTALDH1A1PTGS1APP
SCHEMBL1181119 0.71 PTGS2 (0.73) PTGS2PTGS1
SCHEMBL9214748 0.71 PTGS2 (0.40) PTGS2MAPTKDM4EALDH1A1APP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1831207-A1 AMINOPYRIMIDINE COMPOUNDS AND METHODS OF USE Amgen Inc. (US) 2007-09-12 EP disclosed
WO-2006066172-A1 AMINOPYRIMIDINE COMPOUNDS AND METHODS OF USE AMGEN, INC. (US) 2006-06-22 WO disclosed